Stocks-IDXX-IDEXX Laboratories Inc

IDXX IDEXX Laboratories Inc

495.14 14.81 (3.08%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade
Stocks-IDXX-IDEXX Laboratories Inc
IDXX IDEXX Laboratories Inc
Trade

Overview

Prev Close 480.34
Day's Range 479.77 - 495.61
52 Week Range 371.67 - 582.06
Average Volume (3M) 511.81K
1-Year Return 5.17%
Beta1.2665
Market Cap 39.53B
P/E Ratio47.61
Revenue3.78B
EPS10.0881
Dividend (Yield) 0 (0%)
Sector
Health Technology
Industry
Medical Specialties
CEO
Jonathan J. Mazelsky, MBA
Employees
11,000

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2023: IDEXX Laboratories Inc's revenues increased by 8.72% and amounted to 3.66B. Net income increased by 24.44% to 845.04M. Net assets increased by 143.87% to 1.48B and EPS increased from 8.03 to 10.06.
IDXX's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
60.40%
Net Profit Margin
21.14%
Operating Margin
28.61%
Return On Investment
43.41%
09/23
12/23
03/24
06/24
Total Revenue
915.53M
901.6M
964.1M
1B
Gross Profit
547.98M
526.17M
593.07M
619.16M
Operating Income
275.28M
245.3M
298.96M
263.8M
Net Income
212.23M
194.52M
235.58M
203.3M